Rallybio (RLYB)
NASDAQ:RLYB
US Market
Holding RLYB?
Track your performance easily

Rallybio (RLYB) Financial Statements

236 Followers

Rallybio Financial Overview

Rallybio's market cap is currently ―. The company's EPS TTM is $-1.786; its P/E ratio is -0.62; Rallybio is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 299.00K----
Gross Profit$ 299.00K----
EBIT$ -17.04M$ -19.79M$ -21.11M$ -17.73M$ -18.41M
EBITDA$ -17.00M$ -19.75M$ -21.08M-$ -19.21M
Net Income Common Stockholders$ -16.24M$ -19.03M$ -20.24M$ -18.31M$ -18.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.61M$ 94.17M$ 109.93M$ 121.38M$ 137.84M
Total Assets$ 92.43M$ 99.36M$ 115.62M$ 133.19M$ 147.58M
Total Debt$ 284.00K$ 339.00K$ 392.00K$ 428.00K$ 479.00K
Net Debt$ -88.33M$ -93.84M$ -109.54M$ -120.96M$ -137.36M
Total Liabilities$ 12.41M$ 10.20M$ 9.44M$ 9.61M$ 8.32M
Stockholders Equity$ 80.02M$ 89.16M$ 106.18M$ 123.58M$ 139.26M
Cash Flow-
Free Cash Flow$ -10.42M$ -15.46M$ -11.66M-$ -13.38M
Operating Cash Flow$ -10.42M$ -15.46M$ -11.64M$ -16.47M$ -13.38M
Investing Cash Flow$ 2.60M$ 10.26M$ 16.91M$ 3.07M$ 6.21M
Financing Cash Flow$ 5.19M-$ 72.00K-$ 210.00K
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis